ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102051 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102051; 2) Community: the network communities that were significantly associated with the response to NSC 102051; 3) Molecule: the relationships between components within communities and NSC 102051; 4) MDR: the compounds that were significantly associated with the NSC 102051.

NSC Compound Enrichment Correlation
NSC 736811 Null 0.0430505868034761 -0.12196355
NSC 240529 2,5-Cyclohexadien-1-one, 4-[[4-[bis(2-chloroethyl)amino]phenyl]imino]-2,6-dimethyl- 0.0438391811600409 0.28509999
NSC 24500 2,6-Dimethoxy-p-benzoquinone 0.0438391811600409 0.1314515
NSC 321237 Mercury, (4-aminophenyl)(6-thioguanosinato-N7,S6)- 0.0438391811600409 0.32036292
NSC 341936 Adenosine, 2-bromo-2'-deoxy- 0.0438391811600409 0.1614806
NSC 606172 Camptothecin Derivative 0.0438391811600409 0.34716523
NSC 646127 6H-Pyrido[4,3-b]carbazole, 1,2-dihydro-2,5,9,11-tetra- methyl- 0.0438391811600409 0.16225237
NSC 667904 1-(8-(2,3-dimethoxyphenyl)-7-methyl-7,8-dihydro-6H-[1,3]dioxolo[4,5-g]chromen-6-yl)-2-phenylhydrazine 0.0438391811600409 -0.035841141
NSC 699122 Palisol 0.0438391811600409 0.11339922
NSC 727354 6-[(4-FMOCamino)-1-butyl]-5,6-dihydro-2,3-dimethoxy-8,9-meth ylenedioxy-5,11-dioxo-11H-indeno[1,2-c-isoquinoline 0.0438391811600409 0.084197041
Total:49  Current:44    [First] [Prev] [Next] [Last]